Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation

The treatment of patients with hematological malignancies is often complicated by a number of negative side effects, which include mental disorders, among which cognitive impairment occupies a special place. Psychopathological, psychological, neuropsychological, neurophysiological and neurovisual me...

Full description

Saved in:
Bibliographic Details
Main Authors: D. E. Vybornykh, S. Yu. Fedorova, S. O. Khrushchev, M. Yu. Drokov, E. G. Gemdzhian, L. A. Kuzmina, E. N. Parovichnikova
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2019-07-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
Online Access:https://www.bekhterevreview.com/jour/article/view/245
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693571618177024
author D. E. Vybornykh
S. Yu. Fedorova
S. O. Khrushchev
M. Yu. Drokov
E. G. Gemdzhian
L. A. Kuzmina
E. N. Parovichnikova
author_facet D. E. Vybornykh
S. Yu. Fedorova
S. O. Khrushchev
M. Yu. Drokov
E. G. Gemdzhian
L. A. Kuzmina
E. N. Parovichnikova
author_sort D. E. Vybornykh
collection DOAJ
description The treatment of patients with hematological malignancies is often complicated by a number of negative side effects, which include mental disorders, among which cognitive impairment occupies a special place. Psychopathological, psychological, neuropsychological, neurophysiological and neurovisual methods were used to examine 46 patients with various hematological malignancies during periods prior to allo-HSCT, 1-3 months after allo-HSCT, and 6 months after transplantation. When statistical analysis of data was performed correlation and multivariate analyzes. Patients at each stage of the study identified cognitive impairment caused by a combination of risk factors — the presence of a hematological malignancy, the encephalotropic activity of chemotherapy drugs, and mental, neurological disorders. The characteristic and stable dynamics of CN in the post-transplantation period is traced — a sharp decline in cognitive functions in almost all indicators at once in the early post-transplant period with their gradual recovery by 6 months after allo-HSCT. The attitude of patients to cognitive deficiency also changes during the period of treatment: from anozognosic and hyponozognosic at the pre-transplantation stage to hypernosognostic at long-term periods after allo-HSCT.
format Article
id doaj-art-688ea43c3d3347f89ba3fe75fbbbf6a9
institution DOAJ
issn 2313-7053
2713-055X
language Russian
publishDate 2019-07-01
publisher Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
record_format Article
series Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
spelling doaj-art-688ea43c3d3347f89ba3fe75fbbbf6a92025-08-20T03:20:22ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2019-07-0102203610.31363/2313-7053-2019-2-20-36242Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantationD. E. Vybornykh0S. Yu. Fedorova1S. O. Khrushchev2M. Yu. Drokov3E. G. Gemdzhian4L. A. Kuzmina5E. N. Parovichnikova6ФГБУ «НМИЦ гематологии» Минздрава РоссииNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyThe treatment of patients with hematological malignancies is often complicated by a number of negative side effects, which include mental disorders, among which cognitive impairment occupies a special place. Psychopathological, psychological, neuropsychological, neurophysiological and neurovisual methods were used to examine 46 patients with various hematological malignancies during periods prior to allo-HSCT, 1-3 months after allo-HSCT, and 6 months after transplantation. When statistical analysis of data was performed correlation and multivariate analyzes. Patients at each stage of the study identified cognitive impairment caused by a combination of risk factors — the presence of a hematological malignancy, the encephalotropic activity of chemotherapy drugs, and mental, neurological disorders. The characteristic and stable dynamics of CN in the post-transplantation period is traced — a sharp decline in cognitive functions in almost all indicators at once in the early post-transplant period with their gradual recovery by 6 months after allo-HSCT. The attitude of patients to cognitive deficiency also changes during the period of treatment: from anozognosic and hyponozognosic at the pre-transplantation stage to hypernosognostic at long-term periods after allo-HSCT.https://www.bekhterevreview.com/jour/article/view/245cognitive impairmenthematological malignancieshematopoietic stem cells transplantationmental disordersneurological disordersmultivariate analysis
spellingShingle D. E. Vybornykh
S. Yu. Fedorova
S. O. Khrushchev
M. Yu. Drokov
E. G. Gemdzhian
L. A. Kuzmina
E. N. Parovichnikova
Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
cognitive impairment
hematological malignancies
hematopoietic stem cells transplantation
mental disorders
neurological disorders
multivariate analysis
title Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
title_full Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
title_fullStr Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
title_full_unstemmed Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
title_short Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
title_sort cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
topic cognitive impairment
hematological malignancies
hematopoietic stem cells transplantation
mental disorders
neurological disorders
multivariate analysis
url https://www.bekhterevreview.com/jour/article/view/245
work_keys_str_mv AT devybornykh cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT syufedorova cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT sokhrushchev cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT myudrokov cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT eggemdzhian cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT lakuzmina cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation
AT enparovichnikova cognitiveimpairmentsinpatientswithhematologicalmalignanciespriorandafterallogeneichematopoieticstemcellstransplantation